Colchicine reduces inflammatory cytokines and improves symptoms in HFpEF: an observational pilot study

This study is the first to explore colchicine as an anti-inflammatory treatment for HFpEF. Our results indicate that colchicine can safely and effectively reduce inflammatory markers such as IL-8 and IL-6. After 1 month of treatment, significant improvements were observed in anxiety, depression, and quality of life. These findings support colchicine's potential as a therapeutic option for managing inflammation and improving outcomes in patients with HFpEF.